We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 96.50
Bid: 96.30
Ask: 96.70
Change: 0.70 (0.73%)
Spread: 0.40 (0.415%)
Open: 92.80
High: 96.50
Low: 92.80
Prev. Close: 95.80
HTWS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Equity Placing in Helios Towers PLC

18 Jun 2020 07:00

RNS Number : 3479Q
Citigroup Global Markets Limited
18 June 2020
 

 

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO.596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

Press Release

Successful completion of the sale of ordinary shares in Helios Towers Plc ("Helios Towers" or the "Company")

18 June 2020

Network i2i Limited, wholly owned subsidiary of Bharti Airtel Limited, (the "Seller") hereby announces the sale of 23.1 million existing ordinary shares in Helios Towers ("Placing Shares"), (the "Placing"). The Placing Shares represented approximately 2.3% of Helios Towers' issued ordinary share capital. Following the sale, the Seller will no longer hold any of the Company's issued ordinary share capital.

Gross sale proceeds of the offering amounted to £36.9m, equal to £1.60 for each ordinary share. The sale will be settled on 22 June 2020.

Citigroup Global Markets Limited ("Citi") acted as Joint Bookrunner in connection with the offering. BofA Securities acted as Joint Bookrunner (passive).

Helios Towers will not receive any proceeds from the Placing.Enquiries:

Citigroup Global Markets Limited (Joint Bookrunner)

Ken Robins

Gulfraz Qayyum

Chuba Ezenwa

Mihir Unadkhat

 

+44 (0) 20 7500 5000

 

BofA Securities (Joint Bookrunner (passive))

Amit Shah

Raj Batra

Andrew Briscoe

 

 

+44 (0) 20 7628 1000

 

 

IMPORTANT NOTICE

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions), Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by the Seller or any of its affiliates, that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and, subject to certain exemptions, may not be offered or sold in the United States (as defined in Regulation S under the Securities Act). Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

In the United Kingdom and member states of the European Economic Area, this announcement and any offer if made subsequently is directed exclusively at persons who are "qualified investors" within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) ("Qualified Investors"). In the United Kingdom this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, or (iii) to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

In connection with any offering of the Placing Shares, the Joint Bookrunners and any of their respective affiliates acting as an investor for their own account may take up as a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. They do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

Citi, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority and Merrill Lynch International, which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, are acting on behalf of the Seller and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of its clients or for providing advice in relation to any offering of the Placing Shares. The Joint Bookrunners will not regard any other person as its client in relation to the offering of the Placing Shares.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIEVLBFBQLEBBX
Date   Source Headline
16th Apr 20242:29 pmRNSDirector/PDMR Shareholding
28th Mar 20248:57 amRNSTotal Voting Rights
25th Mar 202410:31 amRNSDoc re Annual Report and Financial Statements
20th Mar 202412:31 pmRNSDirector/PDMR Shareholding
19th Mar 20242:52 pmRNSHolding(s) in Company
19th Mar 20247:56 amRNSHolding(s) in Company
15th Mar 202412:52 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSResults for the year and quarter ended 31 Dec 2023
26th Jan 20249:00 amRNSDirectorate Change
18th Jan 20247:00 amRNSNotice of FY 2023 Results Date & Conference Call
3rd Nov 20237:05 amRNSBlock Listing Interim Review
2nd Nov 20237:00 amRNSQ3 2023 Results
16th Oct 20237:01 amRNSResults of capped tender offer
16th Oct 20237:00 amRNSResults of Tender Offer for Senior Notes
10th Oct 20237:00 amRNSNotice of Q3 2023 Results Date & Conference Call
3rd Oct 20231:29 pmRNSDirector/PDMR Shareholding
28th Sep 20231:34 pmRNSExtension of Early Tender Time
14th Sep 20237:05 amRNSNew Facilities and tender offer of Senior Notes
14th Sep 20237:00 amRNSUp to $400m Tender Offer for Senior Notes
3rd Aug 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSNotice of H1 2023 Results Date & Conference Call
23rd May 20231:39 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirector/PDMR Shareholding
18th May 20232:00 pmRNSDirectorate Change
18th May 20237:00 amRNSQ1 2023 Results
3rd May 202311:25 amRNSBlock Listing Interim Review
27th Apr 20233:39 pmRNS2023 Annual General Meeting Results
17th Apr 20239:44 amRNSNotice of Q1 2023 Results Date & Conference Call
27th Mar 20232:16 pmRNS2022 Annual Report and 2023 Notice of AGM
16th Mar 20237:00 amRNSFinal Results
27th Jan 20237:00 amRNSNotice of FY2022 Results Date & Conference Call
15th Dec 20225:56 pmRNSHolding in Company
8th Dec 20222:55 pmRNSClosing of tower acquisition in Oman
30th Nov 20227:00 amRNSTotal Voting Rights
25th Nov 20227:00 amRNSUpdate on Omantel Tower Portfolio Acquisition
14th Nov 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
9th Nov 20228:53 amRNSHolding(s) in Company
3rd Nov 20227:00 amRNSQ3 2022 Results
6th Oct 20227:00 amRNSNotice of Q3 2022 Results Date & Conference Call
3rd Oct 20227:00 amRNSBlock Listing Application
29th Sep 202212:03 pmRNSOmantel Tower Acquisition Long-Stop Date Extension
18th Aug 20227:00 amRNSDirectorate Change
18th Aug 20227:00 amRNSHalf-year Report
13th Jul 20227:00 amRNSNotice of H1 2022 Results Date & Conference Call
5th Jul 20227:00 amRNSOmantel Tower Acquisition Long-Stop Date Extension
21st Jun 202212:49 pmRNSDirector/PDMR Shareholding
17th Jun 202210:27 amRNSDirector/PDMR Shareholding
7th Jun 20229:57 amRNSOmantel Tower Acquisition Update
5th May 202210:30 amRNSCapital Markets Day 2022
5th May 20227:00 amRNSQ1 2022 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.